Parneet Dehl, VP of Life Sciences at RBCx, discusses the untapped potential in Canada's femtech market, emphasizing the need for funding, education, and inclusivity. The interview explores the challenges femtech founders face, the underfunding issue, and unique obstacles within the life sciences and healthcare sector. Dehl highlights the pivotal role of women founders, calls for increased investor support, and outlines the significant market opportunity, projecting the femtech market's worth to exceed $4.8 trillion by 2025.
You can read the full interview right here.